Biofrontera Inc.
BFRI
Clasificación en acciones
#31616
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization... Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Precio por acción
$0.8002
Capitalización bursátil
$11.88M
Cambio (1 día)
-0.47%
Cambio (1 año)
-72.87%
País
US
Comercio Biofrontera Inc. (BFRI)
Categoría
Healthcare
Historial del precio de la acción de Biofrontera Inc. (BFRI)
Precio más alto de cierre: $2.93 el 2024-06-01
Precio más bajo de cierre: $328.16 el 2006-10-01
Precio más bajo de cierre: $328.16 el 2006-10-01
Historial del precio de la acción de Biofrontera Inc. desde 2006 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2024 | -73.04% |
| 2023 | -68.52% |
| 2022 | -5.85% |
| 2021 | -48.56% |
| 2020 | -30.24% |
| 2019 | -15.14% |
| 2018 | 34.15% |
| 2017 | 41.58% |
| 2016 | 70.60% |
| 2015 | -31.22% |
| 2014 | -36.74% |
| 2013 | -4.76% |
| 2012 | 28.04% |
| 2011 | 56.02% |
| 2010 | -25.62% |
| 2009 | 48.88% |
| 2008 | -87.41% |
| 2007 | -3.58% |
| 2006 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $62.29 | 66.19% |
US
|
|
| $46.29 | 38.28% |
SE
|
|
| $171.04 | 30.37% |
FR
|
|
| $116.24 | 54.18% |
US
|
|
| $59.46 | 0.32% |
IT
|
